Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-?B/Akt signaling in prostate cancer cells

International Journal of Molecular Medicine

Volumn 33, Issue 2, 2014, Pages 317-324

  Kim, Hye Ri ^a   Park, Chan Gi ^a   Jung, Ji Youn ^a  

^a Kongju National University   (South Korea)

Author keywords

Acacetin; Akt; Apoptosis; Human prostate cancer cells; Nuclear factor ?B

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ACACETIN; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CANCER INHIBITION; CELL CULTURE; CELL DEATH; CELL LYSATE; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; ENZYME ACTIVATION; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PARENCHYMA; MALE; MOUSE; MTT ASSAY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAINING; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONES; HUMANS; MALE; MICE; MICE, NUDE; NF-KAPPA B; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84893732777     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1571     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Siegal R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
3. Kar S, Palit S, Ball WB and Das PK: Carnosic acid modulates Akt/IKK/NF-?B signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 17: 735-747, 2012.
4. Kim EJ, Lim SS, Park SY, Shin HK, Kim JS and Park JH: Apoptosis of DU145 human prostate cancer cells induced by dehydrocostus lactone isolated from the root of Saussurea lappa. Food Chem Toxicol 46: 3651-3658, 2008.
5. Linja MJ, Savinainen KJ, Saramäki OR, Tammela TL, Vessella RL and Visakorpi T: Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 61: 3550-3555, 2001.
6. Lam JS, Leppert JT, Vemulapalli SN, Shvarts O and Belldegrun AS: Secondary hormonal therapy for advanced prostate cancer. J Urol 175: 27-34, 2006.
7. Liu LZ, Jing Y, Jiang LL, et al: Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1a pathway. Biochem Biophys Res Commun 413: 299-305, 2011.
8. Singh RP, Agrawal P, Yim D, Agarwal C and Agarwal R: Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: Structure-activity relationship with linarin and linarin acetate. Carcinogenesis 26: 845-854, 2005.
9. Schuier M, Sies H, lllek B and Fischer H: Cocoa-related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia. J Nutr 135: 2320-2325, 2005.
10. Miyazawa M and Hisama M: Antimutagenic activity of flavonoids from Chrysanthemum morifolium. Biosci Biotechnol Biochem 67: 2091-2099, 2003.
11. Martínez-Vázquez M, RamírezApan TO, Lastra AL and Bye R: A comparative study of the analgesic and anti-inflammatory activities of pectolinarin isolated from Cirsium subcoriaceum and linarin isolated from Buddleia cordata. Planta Med 64: 134-137, 1998.
12. Kraft C, Jenett-Siems K, Siems K, et al: In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phytother Res 17: 123-128, 2003.
13. Cholbi MR, Paya M and Alcaraz MJ: Inhibitory effects of phenolic compounds on CC14-induced micresomal lipid peroxi-dation. Experientia 47: 195-199, 1991.
14. Yin Y, Gong FY, Wu XX, et al: Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. J Ethnopharmacol 120: 1-6, 2008.
15. Fong Y, Shen KH, Chiang TA and Shih YW: Acacetin inhibits TPA-induced MMP-2 and u-PA expressions of human lung cancer cells through inactivating JNK signaling pathway and reducing binding activities of NF-kappaB and AP-1. J Food Sci 75: H30-H38, 2010.
16. Shen KH, Hung SH, Yin LT, et al: Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Mol Cell Biochem 333: 279-291, 2010.
17. Hsu YL, Kuo PL and Lin CC: Acacetin inhibits the proliferation of Hep G2 by blocking cell cycle progression and inducing apoptosis. Biochem Pharmacol 67: 823-829, 2004.
18. Park MH, Choi MS, Kwak DH, et al: Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-?B. Prostate 71: 801-812, 2011.
19. Xiao G, Harhaj EW and Sun SC: NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7: 401-409, 2001.
20. Senftleben U, Cao Y, Xiao G, et al: Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499, 2001.
21. Liu YQ, Hu XY, Lu T, et al: Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-?B signaling in prostate cancer cells in vitro and in vivo. PLoS One 7: E38000, 2012.
22. Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241-246, 2001.
23. Chen CD and Sawyers CL: NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 22: 2862-2870, 2002.
24. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN and Price BD: Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18: 7389-7394, 1999.
25. Boreddy SR, Pramanik KC and Srivastava SK: Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway. Clin Cancer Res 17: 1784-1795, 2011.
26. Kaur P, Shukla S and Gupta S: Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: An in vitro and in vivo study. Carcinogenesis 29: 2210-2217, 2008.
27. Manning BD and Cantley LC: AKT/PKB signaling: Navigating downstream. Cell 129: 1261-1274, 2007.
28. Sizemore N, Leung S and Stark GR: Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19: 4798-4805, 1999.
29. Meng F, Liu L, Chin PC and D'Mello SR: Akt is a downstream target of NF-kappa B. J Biol Chem 277: 29674-29680, 2002.
30. Bruckheimer EM and Kyprianou N: Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res 301: 153-162, 2000.
31. Pan MH, Lai CS, Hsu PC and Wang YJ: Acacetin induces apoptosis in human gastric carcinoma cells accompanied by activation of caspase cascades and production of reactive oxygen species. J Agric Food Chem 53: 620-630, 2005.
32. Talib WH and Mahasneh AM: Antiproliferative activity of plant extracts used against cancer in traditional medicine. Sci Pharm 78: 33-45, 2010.
33. Franke TF, Yang SI, Chan TO, et al: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
34. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
35. Song L, Xiong H, Li J, et al: Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-?B pathway in human non-small cell lung cancer. Clin Cancer Res 17: 1839-1849, 2011.
36. Ghosh S, May MJ and Kopp EB: NF-?B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
37. Barkett M and Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 69: 6910-6924, 1999.
38. Karin M and Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
39. Carneiro ML, Peixoto RC, Joanitti GA, et al: Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer. J Nanobiotechnology 11: 4, 2013.